Advanced Health Intelligence Ltd
MYZQF
$0.004
-$0.001-20.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -1.04% | 65.89% | 204.53% | 143.20% | 84.16% |
| Total Other Revenue | -110.27% | -24.23% | 1,376.95% | 1,935.53% | 688.52% |
| Total Revenue | -83.45% | 4.11% | 529.96% | 1,068.55% | 19,238.98% |
| Cost of Revenue | 25.65% | -26.65% | -49.44% | -57.67% | -64.43% |
| Gross Profit | -72.68% | 30.46% | 63.19% | 69.80% | 75.13% |
| SG&A Expenses | -10.34% | -17.62% | -24.01% | 12.60% | 76.12% |
| Depreciation & Amortization | -5.01% | 2.42% | 13.41% | 144.80% | -- |
| Other Operating Expenses | -125.31% | -125.31% | -125.31% | -211.13% | -2,116.26% |
| Total Operating Expenses | -4.86% | -29.74% | -45.86% | -39.41% | -32.90% |
| Operating Income | -6.05% | 31.85% | 54.21% | 47.61% | 41.06% |
| Income Before Tax | -70.71% | 12.56% | 46.48% | 57.30% | 66.34% |
| Income Tax Expenses | 27.59% | 158.44% | 7,666.67% | 322.38% | 198.34% |
| Earnings from Continuing Operations | -66.56% | 7.47% | 40.85% | 51.82% | 61.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.56% | 7.47% | 40.85% | 51.82% | 61.35% |
| EBIT | -6.05% | 31.85% | 54.21% | 47.61% | 41.06% |
| EBITDA | -5.72% | 32.65% | 55.05% | 48.86% | 41.90% |
| EPS Basic | -26.78% | 30.90% | 54.39% | 61.54% | 67.28% |
| Normalized Basic EPS | 7.22% | 44.66% | 62.65% | 59.60% | 56.85% |
| EPS Diluted | -26.78% | 30.90% | 54.39% | 61.54% | 67.28% |
| Normalized Diluted EPS | 7.22% | 44.66% | 62.65% | 59.60% | 56.85% |
| Average Basic Shares Outstanding | 32.22% | 26.50% | 20.42% | 19.62% | 18.72% |
| Average Diluted Shares Outstanding | 32.22% | 26.50% | 20.42% | 19.62% | 18.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
